Urinary levels of tobacco-specific nitrosamine metabolites in relation to lung cancer development in two prospective cohorts of cigarette smokers.
about
Abundant Rodent Furan-Derived Urinary Metabolites Are Associated with Tobacco Smoke Exposure in Humans.Collagen XXIII: a potential biomarker for the detection of primary and recurrent non-small cell lung cancerLung carcinogenesis by tobacco smokeUrinary tobacco smoke-constituent biomarkers for assessing risk of lung cancer.Predicting chemical toxicity effects based on chemical-chemical interactionsUrinary biomarkers of smokers' exposure to tobacco smoke constituents in tobacco products assessment: a fit for purpose approachBiomarkers of Tobacco Exposure: Summary of an FDA-sponsored Public WorkshopClinical trials methods for evaluation of potential reduced exposure productsElimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.Performance of urine cotinine and hypomethylation of AHRR and F2RL3 as biomarkers for smoking exposure in a population-based cohort.Body mass index and smoking-related lung cancer risk in the Singapore Chinese Health Study.Formation and distribution of NNK metabolites in an isolated perfused rat lung.Applying tobacco carcinogen and toxicant biomarkers in product regulation and cancer prevention.It is time to regulate carcinogenic tobacco-specific nitrosamines in cigarette tobacco.Do changes in cigarette design influence the rise in adenocarcinoma of the lung?Carcinogenicity and DNA adduct formation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F-344 rats.Comparison of urine cotinine and the tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and their ratio to discriminate active from passive smokingEvidence supporting product standards for carcinogens in smokeless tobacco products.Toenail nicotine level as a novel biomarker for lung cancer risk.Variation in levels of the lung carcinogen NNAL and its glucuronides in the urine of cigarette smokers from five ethnic groups with differing risks for lung cancer.Racial differences in the relationship between number of cigarettes smoked and nicotine and carcinogen exposure.Urinary levels of the tobacco-specific carcinogen N'-nitrosonornicotine and its glucuronide are strongly associated with esophageal cancer risk in smokers.Elevated levels of 1-hydroxypyrene and N'-nitrosonornicotine in smokers with head and neck cancer: A matched control study.Research opportunities related to establishing standards for tobacco products under the Family Smoking Prevention and Tobacco Control ActGenetic variability in the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL).Self-reported Tobacco use does not correlate with carcinogen exposure in smokers with head and neck cancer.Effect of differing levels of tobacco-specific nitrosamines in cigarette smoke on the levels of biomarkers in smokers.Urinary levels of volatile organic carcinogen and toxicant biomarkers in relation to lung cancer development in smokers.Urinary levels of cigarette smoke constituent metabolites are prospectively associated with lung cancer development in smokers.Increased pouch sizes and resulting changes in the amounts of nicotine and tobacco-specific N-nitrosamines in single pouches of Camel Snus and Marlboro Snus.Alaska Native smokers and smokeless tobacco users with slower CYP2A6 activity have lower tobacco consumption, lower tobacco-specific nitrosamine exposure and lower tobacco-specific nitrosamine bioactivation.Associations Between Genetic Ancestries and Nicotine Metabolism Biomarkers in the Multiethnic Cohort StudyTobacco smoke biomarkers and cancer risk among male smokers in the Shanghai cohort studyEvaluation of tobacco specific nitrosamines exposure by quantification of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human hair of non-smokers.Urinary Metabolite Risk Biomarkers of Lung Cancer: A Prospective Cohort Study.Tobacco Smoking and Lung Cancer: Perception-changing factsHigh throughput liquid and gas chromatography-tandem mass spectrometry assays for tobacco-specific nitrosamine and polycyclic aromatic hydrocarbon metabolites associated with lung cancer in smokers.Exposure and Metabolic Activation Biomarkers of Carcinogenic Tobacco-Specific Nitrosamines.Tobacco-specific N-nitrosamine exposures and cancer risk in the Shanghai Cohort Study: remarkable coherence with rat tumor sitesAdjustment for tobacco smoking and alcohol consumption by simultaneous analysis of several types of cancer.
P2860
Q24170376-AA353492-0286-4003-8F2F-FC6DDCE01FE2Q24600990-740C607B-7E81-42B9-99CB-CB045CBF3CFCQ24625044-E22FD861-3890-46FB-ABF8-F2AB4880196FQ27692101-6B4BEC21-754F-4B0F-82C0-7C4BA94BBEE4Q28486192-677AFDFA-1ED4-4730-BAB1-905A96B2E2A8Q28662000-51750E27-F2A3-40AC-AB72-F05EBA8D98F1Q29248704-00012D10-CB81-423B-BC24-65AD5CBE816DQ33562506-23EDD266-4B52-4A5C-87A2-2258FA6DABAFQ33583823-DFFF58DC-2519-4AF6-9441-2D0A96258F5EQ33614919-5B432EA2-D743-4E15-882D-C7B1315EEB29Q33658535-CF6EB0EB-F231-4A7C-BBC9-31DE01BF3C0AQ33861910-B3CF6206-AED6-4914-A42E-BA2A248C1C82Q33936367-6DBB43B0-C277-4207-94B4-1522A503F53CQ34056291-2B45A7C4-907F-454D-92E4-BF89F14B6204Q34407294-09A8F326-1F74-4EF7-AB87-8C7B3A45DE19Q34586229-94A03E50-E4E9-485A-BC2C-918EBF7D95DDQ34608572-85849133-0D47-4F8B-B105-ACD2E5954B76Q34987618-FE91A525-C1C5-42CE-BA30-ADA5F829F98CQ35017492-72B51947-8A43-4405-8150-BA241BD2B2E5Q35164670-E502C665-654B-4E46-A7AE-1E8018EBCB63Q35200071-132EFC29-8C60-49C7-AE1B-78CA5DA5B13CQ35452161-00DFF6EA-6CBC-45D5-A29B-3E7CAFEB7289Q35566185-7412F27C-4735-4283-84F9-DD94D37E0D7FQ35624461-00454D04-038E-44F9-B3CB-A70E404DEC84Q35638655-4DCF1ABE-49B9-410B-AC8B-E845D92EA9ACQ35883271-4E0BF357-84BE-4BE8-8AF6-FE92D149C207Q36047534-821783A0-98F0-4DA7-A881-C09E1E5D4779Q36061132-3AF63053-EF9D-48B6-9FD0-DEC27CD64D7EQ36085208-C0FC05B8-937C-45A0-854A-5D80AED86024Q36277946-33EF2F9A-5605-4903-A26D-0D04482FF901Q36499756-135FD844-D19E-4A55-82B2-0F8A5CEBD73FQ36722084-5607F734-AF0E-49A8-9CA2-2AC76FB517BCQ36828392-B7DC8DE9-991B-4AA9-94BB-3735C5585CFEQ36835407-25E02EAB-75B5-43D2-8FBA-9B85500642F2Q36963678-05828371-339A-4DA3-9E73-EE187E71DB69Q37109569-53718006-07CE-4BAD-BBD0-82DFCA13C78AQ37243159-EFC85D3E-5D05-4776-B53F-8C873F2525E2Q37499926-379923B8-B373-48DB-8D65-47EF5DB5B15EQ37629435-D796858A-3E7B-4365-8639-2098F81BE0BEQ37639746-2536258F-3256-4D63-84B4-43F037909559
P2860
Urinary levels of tobacco-specific nitrosamine metabolites in relation to lung cancer development in two prospective cohorts of cigarette smokers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Urinary levels of tobacco-spec ...... cohorts of cigarette smokers.
@en
Urinary levels of tobacco-spec ...... cohorts of cigarette smokers.
@nl
type
label
Urinary levels of tobacco-spec ...... cohorts of cigarette smokers.
@en
Urinary levels of tobacco-spec ...... cohorts of cigarette smokers.
@nl
prefLabel
Urinary levels of tobacco-spec ...... cohorts of cigarette smokers.
@en
Urinary levels of tobacco-spec ...... cohorts of cigarette smokers.
@nl
P2093
P2860
P50
P1433
P1476
Urinary levels of tobacco-spec ...... cohorts of cigarette smokers.
@en
P2093
Katie Wickham
Renwei Wang
Shaomei Han
Sharon E Murphy
Stephen S Hecht
Steven G Carmella
Yunhua Fan
P2860
P304
P356
10.1158/0008-5472.CAN-08-4330
P407
P577
2009-03-24T00:00:00Z